Synergic effect of chronic hepatitis C infection and beta thalassemia major with marked hepatic iron overload on liver fibrosis: A retrospective cross-sectional study

BMC Gastroenterology

Volumn 4, Issue , 2004, Pages

  Ardalan, Farid Azmoudeh ^a   Osquei, Mohammad R F ^a   Toosi, Mohsen Nasiri ^a   Irvanloo, Guiti ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FIBROGENESIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IRON OVERLOAD; LIVER BIOPSY; LIVER FIBROSIS; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; THALASSEMIA MAJOR; ADOLESCENT; BETA THALASSEMIA; CROSS-SECTIONAL STUDY; ISOLATION AND PURIFICATION; LIVER CIRRHOSIS;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CROSS-SECTIONAL STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IRON OVERLOAD; LIVER CIRRHOSIS; MALE; RETROSPECTIVE STUDIES;

EID: 10444255328     PISSN: 1471230X     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-4-17     Document Type: Article

References (17)

1. Forget BG: Thalassemia syndromes. Hematology basic principles and practice 3rd edition. Edited by: Hoffman R, Benz E J, Shathl S J, Furie B, Cohen H J, Silberstein L E and McGlare P. Philadelphia, Churchill Livingstone; 2000:485-510.
2. Risdon RA, Barry M, Flynn DM: Transfusional iron overload: the relationship between tissue iron concentration and hepatic fibrosis in thalassaemia. J Pathol 1975, 116: 83-95.
3. Ferrel LD, Theise ND, Scheuer PJ: Acute and chronic viral hepatitis. Pathology of liver 4th edition. Edited by: MacSween R N M, Burt A D, Portmann B C, Ishak K G, Scheuer P J and Anthony P P. London, Churchill Livingstone; 2002:344-349.
4. Costello M, Yungbluth M: Viral infections. Clinical diagnosis and management by laboratory methods 20th edition. Edited by: Henry J B. Philadelphia, W. B. Saunders; 2001:1064-1066.
5. Dore GJ, Freeman AJ, Law M, Kaldor JM: Is severe liver disease a common outcome for people with chronic hepatitis C? J Gastroenterol Hepatol 2002, 17: 423-430.
6. Fargion S, Fracanzani AL, Rossini A, Borzio M, Riggio O, Belloni G, Bissoli F, Ceriani R, Ballare M, Massari M, Trischitta C, Fiore P, Orlandi A, Morini L, Mattioli M, Oldani S, Cesana B, Fiorelli G: Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study. Am J Gastroenterol 2002, 97: 1204-1210.
7. Diwakaran HH, Befeler AS, Britton RS, Brunt EM, Bacon BR: Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection. J Hepatol 2002, 36: 687-691.
8. Angelucci E, Muretto P, Nicolucci A, Baronciani D, Erer B, Gaziev J, Ripalti M, Sodani P, Tomassoni S, Visani G, Lucarelli G: Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood 2002, 100: 17-21.
9. Lee GR: Storage and metabolic disorders. Diagnostic liver pathology 1st edition. Edited by: Lee G R. St. Louis, Mosby; 1994:237-280.
10. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN, et al.: Histological grading and staging of chronic hepatitis. J Hepatol 1995, 22: 696-699.
11. Tung BY, Emond MJ, Bronner MP, Raaka SD, Cotler SJ, Kowdley KV: Hepatitis C, iron status, and disease severity: relationship with HFE mutations. Gastroenterology 2003, 124: 318-326.
12. Fong TL, Han SH, Tsai NC, Morgan TR, Mizokami M, Qian D, Phan C, Goad K, Redeker AG: A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C. J Hepatol 1998, 28: 369-374.
13. Britton RS: Metal-induced hepatotoxicity. Semin Liver Dis 1996, 16:3-12.
14. Olynyk JK, Reddy KR, Di Bisceglie AM, Jeffers LJ, Parker TI, Radick JL, Schiff ER, Bacon BR: Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995, 108: 1104-1109.
15. Van Thiel DH, Friedlander L, Fagiuoli S, Wright HI, Irish W, Gavaler JS: Response to interferon alpha therapy is influenced by the iron content of the liver. J Hepatol 1994, 20: 410-415.
16. Di Marco V, Lo Iacono O, Almasio P, Ciaccio C, Capra M, Rizzo M, Malizia R, Maggio A, Fabiano C, Barbaria F, Craxi A: Long-term efficacy of alpha-interferon in beta-thalassemics with chronic hepatitis C. Blood 1997, 90: 2207-2212.
17. Mirmomen S, Ghofrani H, Pishbijary HF, Daryani NE, Farahvash J, Sharifian RA, Azmodeh F, Malekzadeh R: Safety and efficacy of interferon alfa for the treatment of chronic hepatitis C infected subjects with transfusion dependent thalassemia in Iran. Medical Journal of the Islamic Republic of Iran 2003, 17:87-95.